Natixis Advisors’s Elanco Animal Health ELAN Stock Holding History

Natixis Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48M	Buy	100,815 +7,262	+8%	+$168K	﹤0.01%	1153
2026 Q1	$2.24M	Buy	93,553 +50,068	+115%	+$1.22M	﹤0.01%	1078
2025 Q4	$984K	Buy	+43,485	New	+$946K	﹤0.01%	1260
2023 Q2	–	Sell	-94,594	Closed	-$889K	–	1476
2023 Q1	$889K	Sell	94,594 -41,213	-30%	-$486K	﹤0.01%	1165
2022 Q4	$1.66M	Sell	135,807 -32,630	-19%	-$407K	0.01%	999
2022 Q3	$2.09M	Sell	168,437 -140,041	-45%	-$2.45M	0.01%	880
2022 Q2	$6.05M	Sell	308,478 -1,363	-0.4%	-$32.3K	0.03%	591
2022 Q1	$8.08M	Buy	309,841 +37,518	+14%	+$999K	0.03%	528
2021 Q4	$7.73M	Sell	272,323 -22,519	-8%	-$700K	0.03%	536
2021 Q3	$9.4M	Buy	294,842 +109,996	+60%	+$3.69M	0.04%	444
2021 Q2	$6.41M	Buy	+184,846	New	+$6.1M	0.03%	553
2020 Q2	–	Sell	-15,764	Closed	-$353K	–	1168
2020 Q1	$353K	Sell	15,764 -9,934	-39%	-$272K	﹤0.01%	1097
2019 Q4	$757K	Sell	25,698 -20,484	-44%	-$557K	0.01%	1006
2019 Q3	$1.23M	Sell	46,182 -45,105	-49%	-$1.35M	0.01%	887
2019 Q2	$3.09M	Buy	91,287 +6,574	+8%	+$213K	0.03%	629
2019 Q1	$2.72M	Buy	+84,713	New	+$2.61M	0.02%	654

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Natixis Advisors's ELAN Position: Q2 2026 in Review

Natixis Advisors increased its Elanco Animal Health (ELAN) stake by 7.8% in Q2 2026, buying an estimated $168K and bringing the position to 100,815 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Natixis Advisors first reported a position in ELAN in Q1 2019 and has held it in 16 quarters since. The position peaked at $9.4M in Q3 2021. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Natixis Advisors held 100,815 shares of Elanco Animal Health worth $2.48M as of Q2 2026.
Natixis Advisors bought 7,262 Elanco Animal Health shares in Q2 2026, an estimated $168K.
Elanco Animal Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1153 holding.
Natixis Advisors first reported a position in Elanco Animal Health in Q1 2019 and has held it in 16 quarters since.
Natixis Advisors's Elanco Animal Health position peaked at $9.4M in Q3 2021.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.